Cardiff Oncology Ratios (2011-2025) | CRDF

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)
EBT Margin (Quarter)	-7,558.33%	-10,130.88%	-8,137.21%	-7,162.41%	-14,964.86%	-11,475.82%	-9,669.89%	-7,337.50%	-14,520.48%	-10,328.70%	-6,916.31%	-5,976.92%	-4,881.46%	-7,202.45%	-7,187.88%	-7,804.64%	-12,331.19%	-11,522.31%	-9,381.67%	-2,969.14%
EBIT Margin (Quarter)	-7,558.33%	-10,130.88%	-8,137.21%	-7,162.41%	-14,964.86%	-11,475.82%	-9,669.89%	-7,337.50%	-14,520.48%	-11,303.70%	-7,673.76%	-6,623.08%	-5,333.17%	-7,696.32%	-7,636.97%	-8,325.83%	-13,194.50%	-12,212.40%	-9,978.33%	-3,220.99%
EBITDA Margin (Quarter)	-7,558.33%	-10,130.88%	-8,137.21%	-7,162.41%	-14,964.86%	-11,475.82%	-9,669.89%	-7,337.50%	-14,520.48%	-11,303.70%	-7,673.76%	-6,623.08%	-5,333.17%	-7,696.32%	-7,636.97%	-8,325.83%	-13,194.50%	-12,212.40%	-9,978.33%	-3,220.99%
Operating Margin (Quarter)	-7,558.33%	-10,130.88%	-8,137.21%	-7,162.41%	-14,964.86%	-11,475.82%	-9,669.89%	-7,337.50%	-14,520.48%	-11,303.70%	-7,673.76%	-6,623.08%	-5,333.17%	-7,696.32%	-7,636.97%	-8,325.83%	-13,194.50%	-12,212.40%	-9,978.33%	-3,220.99%
Net Margin (Quarter)	-7,201.39%	-9,945.59%	-8,045.35%	-7,103.76%	-14,863.51%	-11,482.42%	-9,222.58%	-6,799.22%	-13,528.92%	-10,329.63%	-6,905.67%	-5,989.10%	-4,886.34%	-7,229.45%	-7,188.48%	-7,809.93%	-12,330.28%	-11,528.10%	-9,386.67%	-2,972.43%
FCF Margin (Quarter)	-8,172.22%	-6,364.71%	-6,437.21%	-5,487.22%	-14,081.08%	-7,700.00%	-8,531.18%	-6,789.84%	-10,592.77%	-6,495.37%	-6,039.01%	-4,581.41%	-3,814.63%	-5,662.58%	-6,336.97%	-6,746.36%	-12,565.14%	-6,158.68%	-9,043.33%	-2,743.62%
Efficiency
Assets Average (Quarter)	132.15M	136.65M	142.52M	145.43M	144.37M	135.23M	127.45M	119.91M	111.37M	102.00M	92.95M	85.04M	77.84M	70.04M	64.47M	80.04M	91.00M	80.27M	69.76M	62.83M
Equity Average (Quarter)	126.49M	131.87M	136.23M	136.98M	135.26M	125.29M	116.84M	109.78M	101.42M	91.54M	82.20M	73.78M	65.32M	56.64M	50.89M	66.17M	76.91M	64.74M	53.70M	47.09M
Invested Capital (Quarter)	124.82M	138.92M	133.54M	140.42M	130.10M	120.47M	113.21M	106.34M	96.50M	86.58M	77.83M	69.74M	60.89M	52.39M	49.39M	82.95M	70.88M	58.61M	48.79M	45.39M
Asset Utilization Ratio (Quarter)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)	0.96	0.97	0.95	0.94	0.93	0.92	0.92	0.92	0.91	0.89	0.88	0.85	0.82	0.79	0.79	0.85	0.84	0.77	0.76	0.73
Times Interest Earned (Quarter)
Dividends & Payouts
FCF Payout Ratio (Quarter)
Valuation
Enterprise Value (Quarter)	-125.58M	-140.05M	-134.05M	-140.82M	-129.36M	-122.01M	-114.30M	-105.27M	-96.97M	-89.43M	-81.36M	-74.82M	-67.19M	-60.32M	-57.67M	-91.75M	-135.69M	-131.17M	-60.59M	-58.30M
Return Ratios
Return on Sales (Quarter)	-75.58%	-101.31%	-81.37%	-71.62%	-149.65%	-114.76%	-96.70%	-73.38%	-145.20%	-103.29%	-69.16%	-59.77%	-48.81%	-72.02%	-71.88%	-78.05%	-123.31%	-115.22%	-93.82%	-29.69%
Return on Capital Employed (Quarter)	-0.16%	-0.18%	-0.19%	-0.21%	-0.25%	-0.30%	-0.34%	-0.36%	-0.40%	-0.46%	-0.53%	-0.61%	-0.67%	-0.78%	-0.89%	-0.73%	-0.67%	-0.85%	-0.98%	-1.05%
Return on Assets (Quarter)	-0.15%	-0.17%	-0.18%	-0.20%	-0.24%	-0.28%	-0.31%	-0.33%	-0.37%	-0.41%	-0.46%	-0.50%	-0.52%	-0.58%	-0.67%	-0.57%	-0.54%	-0.64%	-0.72%	-0.73%
Return on Equity (Quarter)	-0.16%	-0.18%	-0.19%	-0.21%	-0.25%	-0.30%	-0.34%	-0.36%	-0.40%	-0.45%	-0.52%	-0.57%	-0.62%	-0.72%	-0.84%	-0.69%	-0.63%	-0.79%	-0.94%	-0.97%

Research Tools

Cardiff Oncology Ratios (2011-2025) | CRDF

Create an account

Sign In

Reset Password